In June 2024, the sNDA for TUOYI ® in combination with paclitaxel for injection (albumin-bound) for the first-line treatment ...
22h
Granted Both Orphan Drug & Fast Track designations for Amezalpat (TPST-1120) for the treatment of patients with Hepatocellular Carcinoma (HCC)• Announced Agreement with Roche to Support Advancement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback